Atlas Trials

Red Cell Distribution Width and Lactate Albumin Ratio as Prognostic Markers for Mortality in Sepsis and Septic Shock

Clinical trial NCT05921825 · UNKNOWN

Trial details

NCT number
NCT05921825
Sponsor
Tanta University
Status
UNKNOWN
Study type
OBSERVATIONAL
MoralitySepsisSeptic Shock
Start date
2023-07-01
Primary completion
2024-01-30
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.